Forte Biosciences, Inc.
Hedge Funds Holdings
Last updated:
Forte Biosciences, Inc.‘s stocks are currently a part of 14 hedge funds’ portfolios, which represents 12.63% of the total amount of its stocks outstanding. This makes up a total of 2.19M shares of Forte Biosciences, Inc.. Compared to the previous quarter, the number fell by -42.28% or -1.60M shares fewer. As for the holding position changes, 35.71% (5) of current hedge fund investors increased the number of shares held, 21.43% (3) of current holders sold a part of the shares held, and 14.29% (2) closed the holdings completely.
Hedge funds holding Forte Biosciences (Q2 2018 – Q1 2023)
| Q2 2018 | 0 |
|---|---|
| Q3 2018 | 0 |
| Q4 2018 | 0 |
| Q1 2019 | 1 |
| Q2 2019 | 1 |
| Q3 2019 | 1 |
| Q4 2019 | 1 |
| Q1 2020 | 1 |
| Q2 2020 | 24 |
| Q3 2020 | 47 |
| Q4 2020 | 49 |
| Q1 2021 | 62 |
| Q2 2021 | 75 |
| Q3 2021 | 54 |
| Q4 2021 | 45 |
| Q1 2022 | 45 |
| Q2 2022 | 29 |
| Q3 2022 | 24 |
| Q4 2022 | 30 |
| Q1 2023 | 14 |
Hedge funds changes in Forte Biosciences positions (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2018 | 0 | 0 | 0 | 0 | 0 |
| Q4 2018 | 0 | 0 | 0 | 0 | 0 |
| Q1 2019 | 1 | 0 | 0 | 0 | 0 |
| Q2 2019 | 0 | 0 | 0 | 0 | 1 |
| Q3 2019 | 0 | 0 | 0 | 0 | 1 |
| Q4 2019 | 0 | 0 | 0 | 0 | 1 |
| Q1 2020 | 0 | 0 | 0 | 0 | 1 |
| Q2 2020 | 23 | 1 | 0 | 0 | 0 |
| Q3 2020 | 27 | 8 | 10 | 4 | -2 |
| Q4 2020 | 15 | 19 | 7 | 13 | -5 |
| Q1 2021 | 20 | 20 | 13 | 7 | 2 |
| Q2 2021 | 31 | 23 | 14 | 18 | -11 |
| Q3 2021 | 21 | 16 | 12 | 41 | -36 |
| Q4 2021 | 11 | 16 | 10 | 21 | -13 |
| Q1 2022 | 8 | 6 | 22 | 8 | 1 |
| Q2 2022 | 7 | 6 | 12 | 20 | -16 |
| Q3 2022 | 5 | 6 | 9 | 11 | -7 |
| Q4 2022 | 9 | 5 | 9 | 3 | 4 |
| Q1 2023 | 0 | 5 | 3 | 2 | 4 |
Hedge funds changes in Forte Biosciences stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 113,000 | 0 |
|---|---|---|
| Q3 2018 | 201,000 | 7,000 |
| Q4 2018 | 8,000 | 4,000 |
| Q1 2019 | 700,000 | 83,000 |
| Q2 2019 | 725,000 | 237,000 |
| Q3 2019 | 17,000 | 19,000 |
| Q4 2019 | 2,000 | 0 |
| Q1 2020 | 28,000 | 24,000 |
| Q2 2020 | 548,000 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 1,324,000 | 2,591,000 |
| Q4 2021 | 568,000 | 346,000 |
| Q1 2022 | 104,000 | 4,000 |
| Q2 2022 | 143,000 | 1,314,000 |
| Q3 2022 | 119,000 | 2,000 |
| Q4 2022 | 110,500 | 3,900 |
| Q1 2023 | 519,000 | 707,000 |